Clinical Trial Update: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating ETX-636 in adults with advanced solid tumors and advanced breast cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• ETX-636

Snippet

Sponsor: Ensem Therapeutics | Conditions: Advanced Solid Tumors, Advanced Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING